Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 06:15 PM EDT
Outlook Therapeutics Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | 170.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 29.1K | 28.8K | 85.06K | 28.67K | 28.2K | 28.2K | 11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -29.1K | -28.8K | 85.06K | -28.67K | -28.2K | -28.2K | -11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -12.39M | -21.61M | -22.88M | -19.56M | -18.94M | -10.32M | -12.46M | -18.14M | -6.84M | -15.69M | -13.99M | -17.02M | -18.91M | -13.15M | -13.44M | -11.47M | -12.63M | -14.19M |
Interest Income | n/a | 48.88K | 239.95K | 404.59K | n/a | 188.68K | 305.81K | 395.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -46.35M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.34M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M | -13.11M | -14.46M |
Net Income | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M | -13.11M | -14.46M |
Selling & General & Admin | 7.98M | 11.95M | 10.35M | 8.36M | 5.43M | 5.79M | 7.51M | 7.04M | 6.29M | 5.83M | 5M | 5.78M | 6.69M | 3.28M | 3.5M | 2.93M | 4.1M | 2.24M |
Research & Development | 4.41M | 9.66M | 12.52M | 11.2M | 13.51M | 4.53M | 4.94M | 11.1M | 544.95K | 9.86M | 8.99M | 11.25M | 12.22M | 9.87M | 9.94M | 8.54M | 8.53M | 11.95M |
Other Expenses | 491.00 | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.39M | 21.58M | 22.88M | 19.56M | 18.94M | 10.32M | 12.46M | 18.14M | 6.84M | 15.69M | 13.99M | 17.02M | 18.91M | 13.15M | 13.44M | 11.47M | 12.63M | 14.19M |
Interest Expense | 18.5K | n/a | n/a | n/a | 3.08M | n/a | n/a | 303.00 | n/a | 2.45M | 360.65K | 356.95K | 418.33K | 351.53K | 269.18K | 256.87K | 250.41K | 159.66K |
Selling & Marketing Expenses | n/a | 298.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.39M | 21.61M | 22.88M | 19.56M | 18.94M | 10.32M | 12.46M | 18.14M | 6.84M | 15.69M | 13.99M | 17.02M | 18.91M | 13.15M | 13.44M | 11.47M | 12.63M | 14.19M |
Income Tax Expense | 2.8K | n/a | n/a | n/a | 2.8K | n/a | n/a | n/a | 2.8K | n/a | 800.00 | n/a | 2K | n/a | n/a | n/a | 2K | n/a |
Shares Outstanding (Basic) | 30.87M | 24.23M | 18.55M | 23.28M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
Shares Outstanding (Diluted) | 30.87M | 24.23M | 18.55M | 25.48M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
EPS (Basic) | -1.5 | 0.72 | 0.31 | 1.91 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.6 | -1.35 | -1.6 | -1.8 | -1.6 | -1.59 | -1.4 | -1.74 | -2.37 |
EPS (Diluted) | -1.5 | 0.72 | 0.31 | -0.88 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.6 | -1.35 | -1.6 | -1.8 | -1.6 | -1.59 | -1.4 | -1.8 | -2.37 |
EBITDA | -12.36M | -21.58M | 5.72M | 44.44M | -18.91M | -10.29M | -16.74M | -20.66M | -6.83M | -15.68M | -13.93M | -16.97M | -18.86M | -14.06M | -13.09M | -11.89M | -12.77M | -14.21M |
EBIT | -12.39M | -21.61M | 5.69M | 44.41M | -18.94M | -10.32M | -16.75M | -20.68M | -6.84M | -15.69M | -13.98M | -17.02M | -18.91M | -14.11M | -13.13M | -11.94M | -12.85M | -14.3M |
Depreciation & Amortization | 29.1K | 28.8K | 28.8K | 28.67K | 28.2K | 28.2K | 11.22K | 11.19K | 11K | 10.78K | 51.47K | 51.27K | 51.09K | 50.87K | 50.67K | 48.18K | 82.17K | 81.12K |